US Patent Issued to Merck Sharp & Dohme on June 3 for "Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies" (New Jersey Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,735, issued on June 3, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies" was invented by Valentyn Antochshuk (Cranford, N.J.), Preeti G. Desai (Westfield, N.J.), Yogita Krishnamachari (Scotch Plains, N.J.) and Sahil S. Sangani (Rahway, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides co-formulations of anti-PD-1 antibodies and anti-LAG3 antibodies, and their use in treating various disorders."

The patent was filed on Nov. 6, 2019, under Application No. 17/291,701.

*For further information, including images, charts and tables, please visit: htt...